Isolation and Expansion of Adult Cardiac Stem Cells From Human and Murine Heart

Author:

Messina Elisa1,De Angelis Luciana1,Frati Giacomo1,Morrone Stefania1,Chimenti Stefano1,Fiordaliso Fabio1,Salio Monica1,Battaglia Massimo1,Latronico Michael V.G.1,Coletta Marcello1,Vivarelli Elisabetta1,Frati Luigi1,Cossu Giulio1,Giacomello Alessandro1

Affiliation:

1. From the Department of Experimental Medicine and Pathology (E.M., S.M., M.V.G.L., L.F., A.G.), University La Sapienza, Rome; IRCCS “Neuromed (E.M., S.M., M.V.G.L., L.F., A.G.),” Pozzilli (IS); Department of Histology and Medical Embriology (L.D.A., M.C., E.V., G.C.), University La Sapienza, Rome; Campus-Biomedico University (G.F.), Rome; Institute of Neurobiology and Molecular Medicine (M.B.), Consiglio Nazionale delle Ricerche, Rome; Stem Cell Research Institute (G.S.), Ospedale San Raffaele,...

Abstract

Cardiac myocytes have been traditionally regarded as terminally differentiated cells that adapt to increased work and compensate for disease exclusively through hypertrophy. However, in the past few years, compelling evidence has accumulated suggesting that the heart has regenerative potential. Recent studies have even surmised the existence of resident cardiac stem cells, endothelial cells generating cardiomyocytes by cell contact or extracardiac progenitors for cardiomyocytes, but these findings are still controversial. We describe the isolation of undifferentiated cells that grow as self-adherent clusters (that we have termed “cardiospheres”) from subcultures of postnatal atrial or ventricular human biopsy specimens and from murine hearts. These cells are clonogenic, express stem and endothelial progenitor cell antigens/markers, and appear to have the properties of adult cardiac stem cells. They are capable of long-term self-renewal and can differentiate in vitro and after ectopic (dorsal subcutaneous connective tissue) or orthotopic (myocardial infarction) transplantation in SCID beige mouse to yield the major specialized cell types of the heart: myocytes (ie, cells demonstrating contractile activity and/or showing cardiomyocyte markers) and vascular cells (ie, cells with endothelial or smooth muscle markers).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology

Cited by 1252 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Stem cell therapy for heart failure in the clinics: new perspectives in the era of precision medicine and artificial intelligence;Frontiers in Physiology;2024-01-09

2. Cardiac Stem Cells: Fact or Fiction?;Resident Stem Cells and Regenerative Therapy;2024

3. Paracrine Responses of Cardiosphere-Derived Cells to Cytokines and TLR Ligands: A Comparative Analysis;International Journal of Molecular Sciences;2023-12-08

4. Role of Extracellular Vesicles in Cardiac Regeneration;Extracellular Vesicles - Applications and Therapeutic Potential [Working Title];2023-12-01

5. Cell Therapy in the Treatment of Coronary Heart Disease;International Journal of Molecular Sciences;2023-11-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3